Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas

  • Carlos Murga-Zamalloa
  • , Avery Polk
  • , Walter Hanel
  • , Pinki Chowdhury
  • , Noah Brown
  • , Alexandra C. Hristov
  • , Nathanael G. Bailey
  • , Tianjiao Wang
  • , Tycel Phillips
  • , Sumana Devata
  • , Pradeep Poonnen
  • , Juan Gomez-Gelvez
  • , Kedar V. Inamdar
  • , Ryan A. Wilcox

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)114474-114480
Number of pages7
JournalOncotarget
Volume8
Issue number70
DOIs
StatePublished - 2017

ASJC Scopus Subject Areas

  • Oncology

Keywords

  • C-myc
  • GATA-3
  • PLK-1
  • T-cell lymphoma
  • Volasertib

Cite this